Placebo for Subcutaneous Injection

BIOLOGICAL2 trials

Sponsors

AstraZeneca

Conditions

Chronic PainHealthy ElderlyMild-Moderate Alzheimer's Disease

Phase 1

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

CompletedNCT02036645

AstraZenecaHealthy Elderly, Mild-Moderate Alzheimer's Disease

Start: 2014-02-04End: 2016-09-15Updated: 2019-06-03

A Study of MEDI7352 in Painful Osteoarthritis of the Knee

CompletedNCT02508155

AstraZenecaChronic Pain

Start: 2015-11-17End: 2020-12-23Updated: 2021-04-15